Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Recruiting 12Not yet recruiting 3Active not recruiting 3Completed 2

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Breast Neoplasms 65Neoplasms 50Colorectal Neoplasms 49Prostatic Neoplasms 39Carcinoma, Non-Small-Cell Lung 39Lung Neoplasms 34Pancreatic Neoplasms 27Leukemia, Myeloid, Acute 23Multiple Myeloma 21Recurrence 17Carcinoma, Hepatocellular 17Uterine Cervical Neoplasms 16Ovarian Neoplasms 15Neoplasm Metastasis 14Squamous Cell Carcinoma of Head and Neck 13Head and Neck Neoplasms 13Triple Negative Breast Neoplasms 12Stomach Neoplasms 12Melanoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Glioblastoma 11Endometrial Neoplasms 11Rectal Neoplasms 10Carcinoma, Renal Cell 10Brain Neoplasms 10Advanced Solid Tumors 10Lymphoma, B-Cell 9Disease 9Colonic Neoplasms 9Esophageal Neoplasms 8

Interventions

irinotecan sucrosofate 1Paclitaxel 1Losartan 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Ovarian Epithelial × 30 days × Clear all
NCT07591831 2026-05-18

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07593339 2026-05-18

Sentinel Lymph Node Mapping in Early-Stage Epithelial Ovarian Cancer Surgery

Başakşehir Çam & Sakura City Hospital

Phase NA Not yet recruiting
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07265739 2026-05-06

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Massachusetts General Hospital

Phase 2 Not yet recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡